NIH Weekly Funding Opportunities and Policy Notices
Notice NOT-CA-22-106 from the NIH Guide for Grants and Contracts
Notice NOT-CA-22-100 from the NIH Guide for Grants and Contracts
Notice NOT-HL-22-028 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-165 from the NIH Guide for Grants and Contracts
Notice NOT-HS-22-019 from the NIH Guide for Grants and Contracts
Notice NOT-MD-22-022 from the NIH Guide for Grants and Contracts
Notice NOT-MD-22-021 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-153 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-152 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-151 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-150 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-149 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-148 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-22-007 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. OBrien Kidney Consortium --National Resource Centers (NRCs) to lead a nation-wide effort to advance kidney research. The Consortium will consist of ~8 National Resource Centers (NRCs) and one National Coordinating Center (NCC). The NRCs will establish theme-based cores to develop and nationally share unique resources, tools, technologies, services, and expertise, and to support and expand the pool of investigators pursuing kidney research.
Funding Opportunity RFA-DK-22-008 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. OBrien Kidney Consortium -- National Coordination Center (NCC) to lead a nation-wide effort to advance kidney research. The OBrien Kidney Consortium will consist of ~8 National Resource Centers (NRCs) tasked with developing and sharing specialized kidney resources tools, technologies, services, and expertise and one NCC to lead, manage, and harmonize all aspects of the Consortium. Specifically, the NCC will: (1) provide administrative support and coordination for the entire Consortium, (2) establish and curate a one-stop-shop sharing portal for the entire Consortium, (3) develop and implement a multipronged communication and education plan to maximize national outreach and impact, (4) ensure that patient viewpoints, priorities, and preferences inform all aspects of the Consortium, and (5) administer and manage a national Opportunity Pool program to address gaps and promote collaboration.
Funding Opportunity RFA-ES-22-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports Phase I (R43), Phase II (R44), Direct to Phase II (R44), and Fast Track (R44) Small Business Innovative Research (SBIR) grant applications from small businesses concerns (SBCs) to develop resources and approaches, including panels of cells or model organisms, that reflect the variability in human populations in chemical toxicity testing . Current toxicology testing is often limited to studies conducted in a small number of laboratory rodent strains, which can fail to identify clinically relevant toxicity if the conventional rodent strain is particularly resistant to the toxic effects of the test compound. Cost-effective screening systems with appropriate throughput are needed to better capture this variability in responses to chemical exposure in the population based on individual genetic susceptibility.
Notice NOT-OD-22-159 from the NIH Guide for Grants and Contracts
Notice NOT-OD-22-163 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DA-23-018 from the NIH Guide for Grants and Contracts. To ensure that digital therapeutics that have been or are in the development for SUD are adopted, this funding opportunity concept aims to fund clinical trials that will generate convincing data to improve adoption by the payors.
Notice NOT-OD-22-162 from the NIH Guide for Grants and Contracts